Michael Forbes, CEO of Adastra, stated in his initial press release: “Harm reduction is a critically vital and mainstream matter, and we have been remaining with the forefront of drug laws throughout the board.”"There's a change in the previous means of the drug trade to much more of a modern, technological and electronic era of providing medic